GMRS
GMR Solutions Inc.
Company overview
- Market capitalization
- —
- Employees
- 33,858
- Latest publication
- 2026-09-29
About GMR Solutions Inc.
GMR Solutions Inc. operates as a provider of emergency medical services (EMS), essential alternate-site, out-of-hospital care, and mobile clinical practice groups in United States. It offers emergent medical services; non-emergent services; and other solutions, such as membership programs, standby and special events, national ambulance contract with the federal emergency management agency, and other state agency and health system contracts to coordinate EMS responses. It serves health systems, large regional systems, and smaller independent hospitals, local communities, health systems, payors, public health and local, state, and federal agencies. The company was incorporated in 2015 and is headquartered in Lewisville, Texas.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Revenue | 1,490,286,000USD |
| Other Operating Expenses | 231,900,000USD |
| Total Operating Expenses | 1,433,597,000USD |
| Operating Income | 56,689,000USD |
| Total Other Income Expense Net | -75,987,000USD |
| Labor And Related Expense | 924,522,000USD |
| Income Before Tax | -19,298,000USD |
| Income Tax Expense | 8,980,000USD |
| Equity Method Income Loss | 436,000USD |
| Net Income | -28,278,000USD |
| Net Income Applicable To Common Shares | -115,442,000USD |
| Source | DisclosureDeterministicFinal |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Total Revenue | 5,739,776,000USD | 5,976,198,000USD | 5,394,711,000USD |
| Cost Of Revenue | 3,507,071,000USD | 3,537,483,000USD | 3,316,101,000USD |
| Gross Profit | 2,232,705,000USD | 2,438,715,000USD | 2,078,610,000USD |
| Selling General Administrative | 191,575,000USD | 170,514,000USD | 156,514,000USD |
| Unclassified Operating Expenses | 4,724,083,000USD | 5,084,163,000USD | 4,817,088,000USD |
| Total Operating Expenses | 4,915,658,000USD | 5,254,677,000USD | 4,973,602,000USD |
| Operating Income | 824,118,000USD | 721,521,000USD | 421,109,000USD |
| Interest Expense | 422,667,000USD | 499,252,000USD | 521,163,000USD |
| Net Interest Income | -422,667,000USD | -499,252,000USD | -521,163,000USD |
| Income Before Tax | 316,527,000USD | 114,523,000USD | -160,588,000USD |
| Tax Provision | 110,300,000USD | 94,114,000USD | 42,074,000USD |
| Net Income | 206,227,000USD | 20,409,000USD | -202,662,000USD |
| Net Income From Continuing Ops | 206,227,000USD | 20,409,000USD | -202,662,000USD |
| Reconciled Depreciation | 329,591,000USD | 297,796,000USD | 314,446,000USD |
| Total Other Income Expense Net | -84,924,000USD | -107,746,000USD | -60,534,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Total Assets | 7,429,258,000USD |
| Cash And Equivalents | 420,001,000USD |
| Cash And Short Term Investments | 489,558,000USD |
| Short Term Investments | 69,557,000USD |
| Total Current Assets | 2,022,979,000USD |
| Other Current Assets | 147,372,000USD |
| Other Non Current Assets | 342,271,000USD |
| Total Liabilities | 6,639,995,000USD |
| Total Current Liabilities | 1,005,846,000USD |
| Other Non Current Liabilities | 99,707,000USD |
| Total Stockholder Equity | 789,263,000USD |
| Total Equity Including Noncontrolling Interest | 789,263,000USD |
| Short Long Term Debt | 151,231,000USD |
| Long Term Debt | 4,266,377,000USD |
| Deferred Revenue | 54,029,000USD |
| Net Receivables | 1,166,369,000USD |
| Inventory | 127,819,000USD |
| Property Plant Equipment Net | 1,627,274,000USD |
| Goodwill | 2,180,581,000USD |
| Intangible Assets | 1,171,914,000USD |
| Accounts Payable | 64,054,000USD |
| Short Term Debt | 58,833,000USD |
| Retained Earnings | -181,434,000USD |
| Accumulated Other Comprehensive Income | 7,422,000USD |
| Source | DisclosureDeterministicFinal |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD |
|---|---|---|
| Total Assets | 7,482,045,000USD | 7,116,596,000USD |
| Intangible Assets | 1,204,237,000USD | 1,308,519,000USD |
| Other Current Assets | 128,571,000USD | 124,197,000USD |
| Total Liab | 7,277,890,000USD | 6,928,601,000USD |
| Total Stockholder Equity | 204,155,000USD | 187,995,000USD |
| Capital Stock | 2,000USD | 2,000USD |
| Retained Earnings | -259,492,000USD | -465,719,000USD |
| Good Will | 2,180,581,000USD | 2,180,581,000USD |
| Cash | 609,349,000USD | 352,293,000USD |
| Total Current Assets | 2,132,081,000USD | 1,817,535,000USD |
| Total Current Liabilities | 1,064,429,000USD | 1,015,432,000USD |
| Net Debt | 4,436,560,000USD | 4,192,953,000USD |
| Short Long Term Debt | 147,140,000USD | 162,221,000USD |
| Long Term Debt | 4,898,769,000USD | 4,383,025,000USD |
| Short Term Investments | 78,608,000USD | 82,512,000USD |
| Net Receivables | 1,094,814,000USD | 1,077,821,000USD |
| Inventory | 115,725,000USD | 105,704,000USD |
| Accounts Payable | 60,047,000USD | 54,659,000USD |
| Property Plant Equipment Net | 1,649,566,000USD | 1,523,216,000USD |
| Property Plant Equipment Gross | 2,873,169,000USD | 2,593,674,000USD |
| Common Stock Shares Outstanding | 54,021,728shares | 54,021,728shares |
| Non Current Assets Total | 5,349,964,000USD | 5,299,061,000USD |
| Non Current Liabilities Total | 6,213,461,000USD | 5,913,169,000USD |
| Non Current Liabilities Other | 101,593,000USD | 89,776,000USD |
| Non Currrent Assets Other | 315,580,000USD | 286,745,000USD |
| Net Working Capital | 1,067,652,000USD | 802,103,000USD |
| Unclassified Current Assets | 105,014,000USD | 75,008,000USD |
| Unclassified Current Liabilities | 857,242,000USD | 798,552,000USD |
| Unclassified Non Current Liabilities | 1,213,099,000USD | 1,440,368,000USD |
| Unclassified Equity | 463,645,000USD | 653,712,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Net Income | -28,278,000USD |
| Depreciation | 76,956,000USD |
| Stock Based Compensation | 132,602,000USD |
| Capital Expenditures | -66,400,000USD |
| Source | DisclosurePreliminary |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD |
|---|---|---|---|
| Net Income | 206,227,000USD | 20,409,000USD | -202,662,000USD |
| Depreciation | 329,591,000USD | 297,796,000USD | 314,446,000USD |
| Stock Based Compensation | 2,271,000USD | 14,546,000USD | 6,163,000USD |
| Other Non Cash Items | 49,509,000USD | 76,886,000USD | 32,405,000USD |
| Change To Account Receivables | -16,993,000USD | -96,859,000USD | 41,831,000USD |
| Change In Working Capital | -14,990,000USD | -168,962,000USD | 53,196,000USD |
| Total Cash From Operating Activities | 641,146,000USD | 246,212,000USD | 257,752,000USD |
| Capital Expenditures | -258,542,000USD | -268,617,000USD | -171,009,000USD |
| Free Cash Flow | 382,604,000USD | -22,405,000USD | 86,743,000USD |
| Investments | 2,630,000USD | 93,115,000USD | 4,264,000USD |
| Net Borrowings | 397,158,000USD | -987,269,000USD | -142,175,000USD |
| Total Cash From Financing Activities | -135,844,000USD | -59,240,000USD | -142,175,000USD |
| Sale Purchase Of Stock | -86,000USD | -1,010,000USD | 0USD |
| Change In Cash | 255,327,000USD | 234,451,000USD | -27,504,000USD |
| Begin Period Cash Flow | 368,902,000USD | 134,451,000USD | 161,955,000USD |
| End Period Cash Flow | 624,229,000USD | 368,902,000USD | 134,451,000USD |
| Unclassified Operating Cash Flow | 68,538,000USD | 5,537,000USD | 54,204,000USD |
| Unclassified Financing Cash Flow | -532,916,000USD | 929,039,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q1 2026Quarterly · 2026-03-31 | Product | Commercial Insurance And Managed Care Excluding Medicare And Medicaid Managed Care | 824,416,000 | USD | 0001104659-26-069410 |
| Q1 2026Quarterly · 2026-03-31 | Product | Complementary Revenue | 40,650,000 | USD | 0001104659-26-069410 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Medicaid | 123,966,000 | USD | 0001104659-26-069410 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Medicare | 348,471,000 | USD | 0001104659-26-069410 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Other Third Party Payors | 96,749,000 | USD | 0001104659-26-069410 |
| Q1 2026Quarterly · 2026-03-31 | Product | Health Care Patient Service — Self Payment | 23,324,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Commercial Insurance And Managed Care Excluding Medicare And Medicaid Managed Care | 749,768,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Complementary Revenue | 41,164,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Medicaid | 115,755,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Medicare | 343,886,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Other Third Party Payors | 87,208,000 | USD | 0001104659-26-069410 |
| Q1 2025Quarterly · 2025-03-31 | Product | Health Care Patient Service — Self Payment | 29,626,000 | USD | 0001104659-26-069410 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.